Nowa wersja platformy, zawierająca wyłącznie zasoby pełnotekstowe, jest już dostępna.
Przejdź na


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2015 | 1 | 1 |
Tytuł artykułu

Opening paper 2015- Some comments on Bioglass: Four Eras of Discovery and Development

Treść / Zawartość
Warianty tytułu
Języki publikacji
Historically the function of biomaterials was to replace diseased or damaged tissues. First generation biomaterials were selected to be as bio-inert as possible and thereby minimize formation of scar tissue at the interface with host tissues. Bioactive glasseswere discovered in 1969 and provided for the first time an alternative; strong, stable interfacial bonding of an implant with host tissues. In the 1980’s it was discovered that bioactive glasses could be used in particulae form to stimulate osteogenesiswhich thereby led to the concept of regeneration of tissues. This article summarizes the four eras of development of bioactive glasses that have led from concept of bioactivity to widespread clinical and commercial use, with emphasis on the first composition, 45S5 Bioglassr. The four eras are; A) Era of Discovery, B) Era of Clinical Application, C) Era of Tissue Regeneration, and D) Era of Innovation. Key scientific and technological questions answered for the first three eras are presented. Questions still to be answered for the fourth era are included to stimulate innovation in the field.
Słowa kluczowe

Opis fizyczny
  • Department of Biomedical
    Engineering, Florida Insitute of Technology, Melbourne, FL,
  • [1] L.L. Hench, R.J. Splinter, W.C. Allen, and T.K. Greenlee, Jr. BondingMechanisms at the Interface of Ceramic Prosthetic Materials,J. Biomed. Maters. Res. 2
  • [1] (1971), 117-141 .
  • [2] C.A. Beckham, T.K. Greenlee Jr. and A.R. Crebo, Jr Bone Formationat a Ceramic Implant Interface, Calc.Tissue Res. 8, 165(1971)
  • [3] T.K. Greenlee Jr., C.A. Beckham, A.R. Crebo and J.C. Malmborg,Glass Ceramic Bone Implants, J. Biomed. Mater. Res. 6 (1972),235-244
  • [4] L.L. Hench and H.A. Paschall., Direct Chemical Bonding of BioactiveGlass-Ceramic Materials and Bone, J. Biomed. Mats. Res.Symp. No. 4 (1973), 25-42.[Crossref]
  • [5] L.L. Hench and H.A. Paschall , Histo-Chemical Responses ata Biomaterials Interface, J. Biomed. Mats. Res. No. 5 (Part 1)(1974), 49-64.
  • [6] G. Piotrowski, L.L. Hench,W.C. Allen and G.J. Miller, MechanicalStudies of the Bone-Bioglass Interfacial Bond, J. Biomed.Mater.Res. Symp. 9
  • [4] (1975), 47-61.
  • [7] L.L. Hench, H.A. Paschall, W.C. Allen and G. Piotrowski, InterfacialBehavior of Ceramics Implants, National Bureau of StandardsSpecial Publication 415, May 1975, 19-35.
  • [8] A.E. Clark, L.L. Hench and H.A. Paschall, The Influence of SurfaceChemistry on Implant Interface Histology: A Theoretical Basisfor Implant Materials Selection, J. Biomed. Maters. Res. 10(1976), 161-174.
  • [9] L.L. Hench and A.E. Clark, Adhesion to Bone, in Biocompatibilityof Orthopaedic Implants, D.F. Williams and G.D. Winter, eds.,CRC Press. Boca Raton, Florida, Vol. II, 1982, Chapter 6.
  • [10] J. Wilson, G.H. Pigott, F.J. Schoen, and L.L. Hench, Toxicologyand Biocompatibility of Bioglass, J. Biomed.Mater. Res. 15, 805(1981).
  • [11] L.L. Hench, The story of Bioglass, J. Mater. Sci: Mater Med. 17(2006), 967-978.[Crossref]
  • [12] L.L. Hench, June W. Hench and D.C. Greenspan, Bioglass: AShort History and Bibliography, J. Aust. Ceram. Soc. 40[1](2004), 1-42.
  • [13] L.L. Hench, Bioceramics: From Concept to Clinic, J. Am. Ceram.Soc. 74
  • [7] (1991), 1487-1510.
  • [14] L.L. Hench, Bioceramics., J. Am. Ceram. Soc. 81[7] (1998), 1705-28.
  • [15] I.D. Xynos, M.V.J. Hukkanen, J.J. Batten, I.D. Buttery, L.L. Henchand J.M. Polak, Bioglassr45S5 Stimulates Osteoblast Turnoverand Enhances Bone Formation In Vitro: Implications and Applicationsfor Bone Tissue Engineering., Calcif. Tiss. Int. 67: 321-329 (2000)
  • [16] L.L. Hench, J.M. Polak, I.D. Xynos and L.D.K. Buttery, BioactiveMaterials to Control Cell Cycle, Mat. Res. Innovat. 3:313-323(2000).[Crossref]
  • [17] I.D. Xynos, A.J. Edgar, L.D. Buttery, L.L. Hench and J.M. Polak,Ionic Dissolution Products of Bioactive Glass Increase Proliferationof Human Osteoblasts and Induce Insulin-like Growth FactorII mRNA Expression and Protein Synthesis, Biochem. Biophys.Res. Comm. 276: 461-465 (2000).
  • [18] I.D. Xynos, A.J. Edgar, L.D.K. Buttery, L.L. Hench and J.M. Polak,Gene Expression Profiling of Human Osteoblasts FollowingTreatment with the Ionic Dissolution Products of Bioglassr45S5 Dissolution, J. Biomed. Mater. Res. 55: 151-157 (2001).
  • [19] L.L. Hench, I.D. Xynos, A.J. Edgar, L.D.K. Buttery, J.M. Polak, J.P.Zhong, X.Y. Liu and J. Chang, Gene Activating Glasses, Journalof Inorganic Materials 17 (2002), 897-909.
  • [20] L.L. Hench, Glass and Genes: The 2001 W.E.S. Turner MemorialLecture, Glass Technology 44 (2003), 1-10.
  • [21] L.L. Hench, Characterization of Glass Corrosion and Durability,J. Non-Crystalline Solids 19 (1975) 27-39.
  • [22] A.E. Clark Jr., C.G. Pantano Jr. and L.L. Hench, Auger SpectroscopicAnalysis of Bioglass Corrosion Films, J. Am. Ceram. Soc.59
  • [1-2] (1976), 37-39.
  • [23] Cheol Y. Kim, A.E. Clark and L.L. Hench, Early Stages of Calcium-Phosphate Layer Formation in Bioglass, J. Non-Crystalline Solids 113 (1989), 195-202.
  • [24] L.L. Hench and D.E. Clark, Physical Chemistry of Glass Surfaces,J. Non-Crystalline Solids 28[1] (1978), 83-105.
  • [25] L.L. Hench, ed, An Introduction to Bioceramics-Second Edition,chapters 6,7,8,9,10,11,12, 31, Imperial College Press, London,(2013)
  • [26] H.R. Stanley, L.L. Hench, C.G. Bennett Jr., S.J. Chellemi, C.J. KingIII, R.E. Going, N.J. Ingersoll, E.C. Ethridge, K.L. Kreutziger, L.Loeb and A.E. Clark, The Implantation of Natural Tooth FormBioglassr in Baboons - Long Term Results, Intern. J. Oral Implantology,2 (1981), 26-36.
  • [27] Gerald E. Merwin, James S. Atkins, June Wilson, Larry L. Hench,Comparison of Ossicular ReplacementMaterials in a Mouse EarModel, Otolaryngol. Head Neck Surg. 90 (1982) 461-469.
  • [28] June Wilson, J.S. Atkins, G.E. Merwin and L.L. Hench,Histopathological Evaluation of Interaction between TympanicMembrane and ImplantMaterials, Trans. Soc. For Biomat.Vol.8 195, 1985
  • [29] G. Merwin, L. Rogers, June Wilson and R. Martin, Facial BoneAugmentation using Bioglassrin Dogs., Arch. Otolaryngology,Head and Neck Surgery., Vol. 112, 280-285, 198
  • [30] G.E. Merwin, Bioglassr middle ear prosthesis: preliminary report,Ann. Otol. Rhinol. Laryngol. 95; 1 Pt 1:78-82 January-February (1986).
  • [31] K. Lobel, Ossicular Replacement Prostheses, in Clinical Performanceof Skeletal Prostheses, Hench and Wilson (eds), Chapmanand Hall, Ltd, London, (1996), pp. 214-236
  • [32] P. Griss, D.C. Greenspan, G. Heimke, B. Krempien, R. Buchinger,L.L. Hench and G. Jentschura, Evaluation of a Bioglass CoatedAl2O3 Total Hip Prosthesis in Sheep, J. Biomed. Maters. Res.10
  • [4] (1976), 511-518.
  • [33] O.H. Andersson, G. Liu, K. Kangasniemi and J. Juhanjoa, Evaluationof the Acceptance of Glass in Bone, 1. Maters. Sci., Med. 3 (1992), 145-150.
  • [34] N.C. Lindfors, J.T. Heikkila, I. Koski, K. Mattila and A.J. Aho,Bioactive glass and autogenous bone as bone graft substitutesin benign bone tumors., J. Biomed. Mater. Res. B. Appl. Biomater.,90 (2009), 131-6.
  • [35] J. McAndrew, C. Efrimescu, E. Sheehan and D. Niall, Through thelooking glass; bioactive glass S53P4 (BonAliver ) in the treatmentof chronic osteomyelitis., Ir. J. Med. Sci., 182 (2013), 509-11.
  • [36] K. Pernaa, I. Koski, K. Mattila, E. Gullichsen, Heikkila J, Aho A,Lindfors N. Bioactive glass S53P4 and autograft bone in treatmentof depressed tibial plateau fractures - a prospective randomized11-year follow-up, J Long Term Eff Med Implants 21(2011), 139-48.
  • [37] J. Sarin, R. Grenman, K. Aitasalo and J. Pulkkinen, Bioactiveglass S53P4 in mastoid obliteration surgery for chronic otitismedia and cerebrospinal fluid leakage, Ann. Otol. Rhinol. Laryngol.121 (2012), 563-9.
  • [38] T. Kokubo, S. Ito, S. Sakka and T. Yamamuro, Formation of aHigh-Strength Bioactive Glass - Ceramic in the System MgOCaO-SiO2-P2O5, J. Mater. Sci. 21, 536 (1986).[Crossref]
  • [39] T. Yamamuro, A/W Glass-Ceramics: Clinical Applications, Introductionto Bioceramics, 2nd Edition, L.L. Hench, ed, ImperialCollege Press, Chapter 14, 189-208 (2013).
  • [40] H.R. Stanley, Alveolar Ridge maintenance using endosseouslyplaced Bioglass (45S5) Cones, Encyclopedic, Handbook of Biomaterialsand Bioengineering; Part B: Applications Volume 2,D.L. Wise et al. (eds), (1995) Marcel Dekker Inc, New York, NY,pp. 1559-1616
  • [41] H.R.Stanley, A.E. Clark and L.L. Hench, Alveolar Ridge MaintenanceImplants, Clinical Performance of Skeletal Prostheses,L.L. Hench and JuneWilson, Eds. Chapman and Hall, Publishers,London, England, (1995) 255-270
  • [42] M.B. Hall, H.R. Stanley, C. King, F. Colaizzi, D. Spilman and L.L.Hench, Early Clinical Trials of 45S5 Bioglassr for EndosseousRidge Maintenance with a New Endosseous Implant Material, J.Prosthetic Dentistry, 58[5] (1987), 607-613
  • [43] Harold R. Stanley, Matthew B. Hall, Arthur E. Clark, Caleb J.King III and Larry L. Hench, Joseph J. Berte, Using 45S5 Bioglass§Cones as Endosseous Ridge Maintenance Implants toPrevent Alveolar Ridge Resorption: A 5-Year Evaluation, Int. J.Oral Maxillofac. Implants, 12 (1997), 95-105.
  • [44] JuneWilson, A.E. Clark, M. Hall and L.L. Hench, Tissue Responseto Bioglassr Endosseous Ridge Maintenance Implants, J. OralImplantology, XIX
  • [4], (1993), 295-302
  • [45] A.M. Weinstein, J.J. Klawitter and S.D. Cook, Implant-bone interfacecharacteristics of bioglass dental implants, J. Biomed.Mater. Res., 14, 1:23-9, January (1980).
  • [46] J. Wilson, E. Douek and K. Rust, BioglassrMiddle Ear Devices:Ten year Clinical Results, Bioceramics 8, (1995) J. Wilson, L.L.Hench and D. Greenspan, Eds. Elsevier Science, Oxford, England
  • [47] K.R. Rust, G.T. Singleton, J. Wilson, P.J. Antonelli, Bioglass middleear prosthesis: long-term results, Am. J. Otol., 17 (1996), 371-4.
  • [48] J. Wilson, S. Low, A. Fetner and L.L. Hench, Bioactive Materialsfor Periodontal Treatment: A Comparative Study, in Biomaterialsand Clinical Applications, A. Pizzoferrato, P.G. Marchetti, A.Ravaglioli and A.J.C. Lee, eds., Elsevier Science Publishers, Amsterdam,(1987), 223-228.
  • [49] J.Wilson and S.B. Low, Bioactive Ceramics for Periodontal Treatment:Comparative Studies in the Patus Monkey, J. Appl. Biomaterials,Vol 3 (1992), 123-169
  • [50] H. Oonishi, L.L. Hench, J. Wilson, F. Sugihara, E. Tsuji, S. Kushitaniand H. Iwaki, Comparative Bone Growth Behaviour in Granulesof BioceramicMaterials of Various Sizes, J. Biomed.Mater.Res. 44 (1999), 31-43
  • [51] H. Oonishi, L.L. Hench, J. Wilson, F. Sugihara, E. Tsuji, M.Matsuwura, S. Kin, T. Yamamoto and S. Mizokawa, QuantitativeComparison of Bone Growth Behaviour in Granules inBioglassr, A-W Glass Ceramic, and Hydroxyapatite, J. Biomed.Mater. Res. 51, (2000), 37-46.
  • [52] J.R. Jones, Review of bioactive glass: From Hench to Hybrids,Acta Biomater, 9[1] (2012), 4457-4486.
  • [53] L.L. Hench, ed, Introduction to Bioceramics, 2nd edition, ImperialCollge Press, (2013) Chapters 6,7,8,9,10,11,12,31
  • [54] D. Wheeler, E.J. Eschbach, R.G. Hoellrich, M.J., Montfort, D.L.Chamberland, Assessment of resorbable bioactive material forgrafting of critical-size cancellous defects, J. Orthop. Res., 2000Jan, 18 (1): 140-8 10716290
  • [55] L.L. Hench, Bioactive Glasses: Gene Expression, An Introductionto Bioceramics, 2nd edition, L.L. Hench, ed, Imperial CollegePress, London, (2013), chapter 4, 71-86
  • [56] R.C. Bielby, I.S. Christodoulou and R.S. Pryce et al., (2004) Timeand concentration-dependant effects of dissolution products of58S sol-gel bioactive glass on proliferation and differentiationof murine and human osteoblasts, Tissue Eng. 10, 1018-1026.[Crossref]
  • [57] I. Christodoulou, L.D.K. Buttery and P. Saravanapavan et al.,(2005), Characterization of human fetal osteoblasts by microarrayanalysis following stimulation with 58S bioactive gel-glassionic dissolution products, J. Biomed.Mater. Res. 77B, 431-446.
  • [58] A. Hoppe, N.S. Güldal, A.R. Boccaccini, A review of the biologicalresponse to ionic dissolution products from bioactive glassesand glass-ceramics, Biomaterials 32 (2011), 2757-2774.
  • [59] R.M. Day, A.R. Boccaccini, S. Shurey, J.A. Roether, A. Forbes, L.L.Hench, S.M. Gabe, Assessment of polyglycolic acid mesh andbioactive glass for soft-tissue engineering scaffolds, Biomaterials25 (2004), 5857-5866.
Typ dokumentu
Identyfikator YADDA
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.